GAMMELLA, ELENA
GAMMELLA, ELENA
Dipartimento di Scienze Biomediche per la Salute
Adenosine A2A receptor but not HIF-1 mediates tyrosine hydroxylase induction in hypoxic PC12 cells
2010 E. Gammella, G. Cairo, L. Tacchini
Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells
2008 E. Alchera, L. Tacchini, C. Imarisio, C. Dal Ponte, C. De Ponti, E. Gammella, G. Cairo, E. Albano, R. Carini
Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure
2014 L. Ostergaard, A. Rudiger, S. Wellmann, E. Gammella, B. Beck Schimmer, J. Struck, M. Maggiorini, M. Gassmann
Cobalamin deficiency-induced down-regulation of p75-immunoreactive cell levels in rat central nervous system
2007 E. Mutti, D. Veber, B. Stampachiacchiere, V. Triaca, E. Gammella, L. Tacchini, L. Aloe, G. Scalabrino
Dual Role of ROS as Signal and Stress Agents : Iron Tips the Balance in favor of Toxic Effects
2016 E. Gammella, S. Recalcati, G. Cairo
Dysregulation of iron metabolism in cancer stem cells
2018 S. Recalcati, E. Gammella, G. Cairo
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells
2017 R. Chiara, E. Gammella, M. Correnti, P. Buratti, F. Elisa, A. Jesper B, A. Gianfranco, G. Shannon, A. Domenico, I. Pietro, G. Cairo, S. Recalcati
Erythropoietin’s inhibiting impact on hepcidin expression occurs indirectly
2015 E. Gammella, V. Diaz, S. Recalcati, P. Buratti, M. Samaja, S. Dey, C.T. Noguchi, M. Gassmann, G. Cairo
Evidence of synergistic/additive effects of sildenafil and erythropoietin in enhancing survival and migration of hypoxic endothelial cells
2013 E. Gammella, C. Leuenberger, M. Gassmann, L. Ostergaard
Excessive Erythrocytosis Is Not Associated With Altered Iron Homeostasis in Men From the World's Highest City
2023 G. Cairo, B. Champigneulle, M. Correnti, E. Gammella, S. Recalcati, D. Girelli, A. Castagna, A. Meinild Lundby, I. Hancco, C. Chirica, D. Guergour, L. Oberholzer, E. Stauffer, C. Lundby, A. Pichon, J.V. Brugniaux, S. Doutreleau, S. Verges, P. Robach
Hepcidin as possible new indirect biomarker for blood doping : a commentary = Epcidina come possibile nuovo biomarcatore indiretto per doping ematico : commento
2021 P. Robach, S. Recalcati, E. Gammella, G. Cairo
Indirect down-regulation of nuclear NF-kB levels by cobalamin in the spinal cord and liver of the rat
2008 D. Veber, E. Mutti, L. Tacchini, E. Gammella, G. Tredici, G. Scalabrino
Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure
2021 P. Robach, E. Gammella, S. Recalcati, D. Girelli, A. Castagna, M. Roustit, C. Lundby, A. Lundby, P. Bouzat, S. Vergès, G. Séchaud, P. Banco, M. Uhr, C. Cornu, P. Sallet, G. Cairo
Iron availability in tissue microenvironmen t: The key role of ferroportin
2021 E. Gammella, M. Correnti, G. Cairo, S. Recalcati
Iron levels in polarized macrophages: regulation of immunity and autoimmunity
2012 S. Recalcati, M. Locati, E. Gammella, P. Invernizzi, G. Cairo
Iron metabolism in liver cancer stem cells
2019 S. Recalcati, M. Correnti, E. Gammella, C. Raggi, P. Invernizzi, G. Cairo
Iron Mining for Erythropoiesis
2022 M. Correnti, E. Gammella, G. Cairo, S. Recalcati
Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms
2015 E. Gammella, S. Recalcati, I. Rybinska, P. Buratti, G. Cairo
Ironing out Macrophage Immunometabolism
2019 S. Recalcati, E. Gammella, G. Cairo
Lack of macrophage ferroportin affects wound healing
2014 S. Recalcati, E. Gammella, P. Buratti, M. Locati, G. Cairo